Cytek’s commitment to expanding access to advanced cytometry is a vital contribution to global public health. By supporting under-resourced labs, they’re helping ensure that essential research can ...

Challenging a long-standing assumption regarding the adult brain, recent research has demonstrated that individuals can ...

Analytical and process development (PD/AD) strategies directly impact how quickly and reliably cell therapies reach patients.

Leiden researchers have found clues to why a rare pregnancy disorder is mild in some babies but life-threatening in others.

Slingshot Biosciences, the leader in precision-engineered cell mimic controls, announced a strategic collaboration with Cellares, the first Integrated Development and Manufacturing Organization (IDMO) ...

As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists ...

Australian Patent Office accepts bioAffinity Technologies' patent application for its platform technology to assess lung health and predict disease.

To combine TruCytes Biomarker Controls with the Cell Q platform to enhance quality and automation.

This flexibility enables faster experimental setup, reconfiguration of panels, expanded donor-cohort coverage, including less common alleles, and integration with advanced flow and mass cytometry or ...

Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...